Thursday, December 7, 2023
No Result
View All Result
No Result
View All Result

BridgeBio Pharma (BBIO) Stock Forecast & Price Prediction

Estimation of the future price movement of BridgeBio Pharma stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $32.41

Concensus $18.00

Low $17.00

Median $18.00

High $19.00

Based on analysts projections #BBIO is expected to experience a price decline over the next year.

The current average BBIO price target, as estimated by these analysts, is $18.00.

The predictions for the future BBIO stock price range from a low of $17.00 to a high of $19.00, highlighting the variability of market expectations for BBIO.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

BBIO stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
J.P. Morgan November 18, 2022 Sell 19.00 9.58
Dane Leone
Raymond James 		March 17, 2022 Sell 17.00 10.76

BridgeBio Pharma (BBIO) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if BridgeBio Pharma is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 07/12/2023

Altman Z-Score: -5.2

Piotroski Score: 3.0

ESG Score

Updated on: 07/12/2023

Environmental: 81.8

Social: 75.4

Governance: 73.1

Financial Health

Updated on: 07/12/2023

DCF: Strong Buy

ROE: Buy

ROA: Sell

Debt to equity ratio: Sell

Price to earnings ratio: Sell

Price to book ratio: Sell

BBIO Discounted Cash Flow

Updated on: 07/12/2023

$35.789
Discounted Cash Flow Value

$32.410
Current Price

BBIO Revenues by Segment

Updated on: 07/12/2023

License
$80,000.00

Revenue from Contract with Customer, Excluding Assessed Tax

BBIO Revenues by Region

Updated on: 07/12/2023

No available data

BBIO Notes Due

Updated on: 07/12/2023

CIKExchangeTitle

There are no data to display

BridgeBio Pharma (BBIO) Social Sentiments

Monitoring bullish and bearish sentiments towards BridgeBio Pharma on Twitter and Stocktwits could help to forecast an upward or downward trend in BridgeBio Pharma stock price.

BridgeBio Pharma Stock Forecast: Analyzing the Company's Promising Pipeline for Rare Genetic Diseases and Oncology

BridgeBio Pharma is a biopharmaceutical company that develops innovative therapies for diseases with high unmet medical needs. With stock ticker BBIO, the company operates in the Biotechnology sector. Here we will discuss BridgeBio Pharma and its recent stock forecast. Founded in 2015, BridgeBio Pharma focuses on developing drugs for rare genetic diseases. It has a diverse portfolio of more than... Read more

BridgeBio Pharma: The Biotechnology Industry's Promising Player for Stock Prediction

The Biotechnology Industry: Stock Prediction for BridgeBio Pharma The biotechnology sector has been one of the most dynamic and innovative industries in recent years. According to a report by Global Market Insights, the global biotech market is expected to reach over $775 billion by 2024, with a compound annual growth rate (CAGR) of 9.9%. This growth is driven by rising... Read more
No Result
View All Result

© 2023 Best Stocks